TearSolutions, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2013-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.tearsolutions.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome
Phase 1
Completed
- Conditions
- Primary Sjögren SyndromeDry Eye
- Interventions
- Drug: 0.005% LacripepDrug: 0.01% LacripepDrug: Placebo
- First Posted Date
- 2017-07-21
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- TearSolutions, Inc.
- Target Recruit Count
- 204
- Registration Number
- NCT03226444
- Locations
- 🇺🇸
University of Alabama Eye Center, Birmingham, Alabama, United States
🇺🇸Doctor My Eyes / Stephen Cohen, OD, PC, Scottsdale, Arizona, United States
🇺🇸Schwartz Laser Eye Center, Scottsdale, Arizona, United States
News
No news found